Detalles de la búsqueda
1.
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Future Oncol;
19(22): 1523-1534, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199326
2.
Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors.
Future Oncol;
18(24): 2627-2638, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699077
3.
The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Oncologist;
26(2): e279-e289, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098199
4.
In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma.
Oncologist;
27(7): e606-e607, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552454
5.
Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
J Virol;
89(15): 7944-54, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25995245
6.
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Ther Adv Med Oncol;
16: 17588359231217959, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249330
7.
Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer: A Multicenter Randomized Clinical Trial.
JAMA Netw Open;
7(5): e2410421, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739392
8.
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Ther Adv Med Oncol;
15: 17588359231193722, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667781
9.
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res;
29(3): 560-570, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455147
10.
A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers.
Cancers (Basel);
14(17)2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077651
11.
Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma.
Laryngoscope;
132(9): 1792-1797, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043989
12.
Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.
Sci Transl Med;
14(648): eabh1261, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675434
13.
Initial Referring Physician and Radiologist Experience with Neck Imaging Reporting and Data System.
Laryngoscope;
132(2): 349-355, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272871
14.
Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status.
Front Oncol;
12: 939118, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36110959
15.
Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO.
Front Oncol;
12: 946320, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36686772
16.
Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Ther Adv Med Oncol;
14: 17588359221122729, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36312814
17.
Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
Head Neck;
44(11): 2571-2578, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047613
18.
Patient Selection for Transoral Robotic Surgery (TORS) in Oropharyngeal Squamous Cell Carcinoma: What the Surgeon Wants to Know.
Top Magn Reson Imaging;
30(2): 117-130, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33828063
19.
Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma.
J Med Imaging Radiat Oncol;
65(6): 796-805, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309212
20.
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel);
13(22)2021 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830888